Health Care / Chemicals & Pharmaceuticals
Congressional stock trading activity sourced from STOCK Act financial disclosures.
Federal contract context is also available for matched USAspending recipients tied to PFE.
Total Trades
167
Members
44
Purchases
69
Sales
97
Avg Conflict
8 / 100
High Conflict
0
Total disclosed volume: $1,342,167 - $5,255,000 · Latest trade: Jun 8, 2026
Matched federal spending records can add context when a heavily traded company is also receiving public money. These recipient matches come from USAspending and should be read alongside, not instead of, the underlying trade filings.
Matched recipients
2
Tracked awards
1,153
Matched spending
$1.4B
PFIZER INC matches USAspending recipient PFIZER INC, with approximately $1,278,424,390 in tracked federal spending during the queried window.
PFIZER INC matches USAspending recipient MERIDIAN MEDICAL TECHNOLOGIES, LLC, with approximately $96,855,349 in tracked federal spending during the queried window.
24
Members
119
Trades
8 / 100
Avg Score
20
Members
48
Trades
7 / 100
Avg Score
4 Form 4 transactions by 4 insiders in the last 90 days. Buys and sales below count open-market transactions only — Form 4 codes P and S. Grants, option exercises and shares withheld for tax move the share count but are not decisions to trade.
Open-market buys
3
Open-market sales
1
Net shares, all codes
+111,585
Buys per sale
3.00
| Insider | Role | Date | Transaction | Shares | Price | Total Value | Filing |
|---|---|---|---|---|---|---|---|
| BOURLA ALBERT | Chairman & CEO | Aug 12, 2026 |
One card per congressional trade. Where several insiders filed in the same window, the card names the largest and counts the rest.
Tommy Tuberville sold PFE 1 day before DAMICO JENNIFER B., SVP & Controller, reported sold on a Form 4.
| Date▼ | Member↕ | Type↕ | Amount↕ | Owner | Conflict↕ |
|---|---|---|---|---|---|
| Jun 8, 2026 | Tommy Tuberville | sale | $15,001 - $50,000 | self | 0 / 100 |
| Mar 24, 2026 | Kelly Armstrong | sale | $50,001 - $100,000 | self | 0 / 100 |
| Mar 13, 2026 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| Feb 10, 2026 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Dec 31, 2025 | J. French Hill | sale | $100,001 - $250,000 | self | 35 / 100 |
| Dec 19, 2025 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Aug 5, 2025 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| Aug 4, 2025 | Lisa C. McClain | sale | $1,001 - $15,000 | spouse | 7 / 100 |
| Jul 16, 2025 | Lisa C. McClain | purchase | $1,001 - $15,000 | spouse | 36 / 100 |
| Jun 17, 2025 | Julia Letlow | purchase | $1,001 - $15,000 | self | 18 / 100 |
| Jun 3, 2025 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 36 / 100 |
| Jun 3, 2025 | Ron Wyden | sale | $1,001 - $15,000 | self | 43 / 100 |
| May 30, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| May 15, 2025 | Robert P. Bresnahan, Jr. | purchase | $15,001 - $50,000 | self | 26 / 100 |
| Apr 29, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Apr 21, 2025 | Bruce Westerman | sale | $1,001 - $15,000 | self | 14 / 100 |
| Apr 11, 2025 | Jefferson Shreve | sale | $15,001 - $50,000 | self | 32 / 100 |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. | sale | $15,001 - $50,000 | self | 2 / 100 |
| Mar 31, 2025 | Gilbert Ray Cisneros, Jr. | sale | $15,001 - $50,000 | self | 0 / 100 |
| Mar 10, 2025 | Carol D. Miller | sale | $15,001 - $50,000 | spouse | 1 / 100 |
| Mar 10, 2025 | Carol D. Miller | sale | $1,001 - $15,000 | self | 38 / 100 |
| Mar 3, 2025 | Bruce Westerman | purchase | $1,001 - $15,000 | self | 37 / 100 |
| Feb 26, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. | purchase | $15,001 - $50,000 | self | 2 / 100 |
Other Health Care stocks traded by members of Congress.
| 38,000 |
| $26.34 |
| $1M |
| SEC Filing |
| BLAYLOCK RONALD E | Director | Aug 5, 2026 | Open-market buy | 39,231 | $25.46 | $998,821 | SEC Filing |
| Buckley Mortimer J | Director | Aug 5, 2026 | Open-market buy | 37,632 | $25.52 | $960,369 | SEC Filing |
| DAMICO JENNIFER B. | SVP & Controller | Aug 5, 2026 | Open-market sale | 3,278 | $25.40 | $83,261 | SEC Filing |
| DAMICO JENNIFER B. | SVP & Controller | Jun 9, 2026 | Open-market sale | 2,000 | $25.70 | $51,400 | SEC Filing |
ABBOTT LABORATORIES